SCHEMBL2866705

SCHEMBL2866705

CCCCOP([O])(=O)OCCCC

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.67
LPAR3 Q9UBY5 5/20 0.50
LPAR1 Q92633 3/20 0.50
LPAR2 Q9HBW0 3/20 0.50
TSHR P16473 1/20 0.50
LMNA P02545 1/20 0.44
ESR1 P03372 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CDC25A P30304 1/20 0.44
AGTR1 P30556 1/20 0.44
AKT1 P31749 1/20 0.44
ADRA1A P35348 1/20 0.44
KCNH2 Q12809 1/20 0.44
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3261925 0.92 LPAR3 (0.60) CYP3A4LPAR3LPAR1LPAR2TSHR
SCHEMBL17333149 0.91 CYP3A4 (0.59) CYP3A4LPAR3LPAR1LPAR2TSHR
SCHEMBL55462 0.90 LPAR3 (0.64) CYP3A4LPAR3LPAR1LPAR2LMNA
SCHEMBL6959795 0.90 LPAR3 (0.64) CYP3A4LPAR3LPAR1LPAR2LMNA
SCHEMBL17333406 0.85 CYP3A4 (0.72) CYP3A4LPAR3LPAR1LPAR2TSHR
SCHEMBL6959839 0.82 CYP3A4 (0.43) CYP3A4LPAR3LPAR1LPAR2TSHR
SCHEMBL17333526 0.80 CYP3A4 (0.48) CYP3A4LPAR3LPAR1LPAR2TSHR
SCHEMBL27895927 0.80 CYP3A4 (1.00) CYP3A4LPAR3LPAR1LPAR2TSHR
SCHEMBL11830671 0.80 CYP3A4 (0.70) CYP3A4LPAR3LPAR1LPAR2TSHR
SCHEMBL1020179 0.80 CYP3A4 (1.00) CYP3A4LPAR3LPAR1LPAR2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024024438-A1 CLATHRATE COMPOUND AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, RESIN COMPOSITION, POLYMER, CURED PRODUCT, AND LAMINATE 富士フイルム株式会社 2024-02-01 WO disclosed
WO-2024004492-A1 PHOTOSENSITIVE COMPOSITION, TRANSFER FILM, LAMINATE, AND METHOD FOR MANUFACTURING SAME, AND MICRO LED DISPLAY 富士フイルム株式会社 2024-01-04 WO disclosed
WO-2024004793-A1 COMPOUND, COMPOSITION, FILM, METHOD FOR PRODUCING COLORED COMPOSITION, AND METHOD FOR PRODUCING LAMINATE FOR DISPLAY ELEMENT 富士フイルム株式会社 2024-01-04 WO disclosed
WO-2023190070-A1 COMPOUND, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, RESIN COMPOSITION, POLYMER, CURED PRODUCT, AND LAMINATE 富士フイルム株式会社 2023-10-05 WO disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
CN-116490574-A Compound, tautomer thereof or salt thereof, process for producing the same, coloring composition, method for dyeing, and dyed article 富士胶片株式会社 2023-07-25 CN disclosed
EP-4212591-A1 COMPOUND, TAUTOMER OF SAME OR SALT OF SAID COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD AND DYED ARTICLE FUJIFILM Corporation (JP) 2023-07-19 EP disclosed
WO-2023042484-A1 COMPOUND OR TAUTOMER THEREOF, COLORED COMPOSITION, DYED OBJECT, AND DYED FABRIC AND PRODUCTION METHOD THEREFOR 富士フイルム株式会社 2023-03-23 WO disclosed
WO-2023042483-A1 COMPOUND, TAUTOMER THEREOF, SALT THEREOF WITH ALKALI METAL OR ORGANIC BASE, COMPOSITION FOR REVERSIBLE COLOR DEVELOPMENT, DYED MATERIAL, COMPOSITION FOR CULTURE MEDIUM FOR DETECTING ENTEROHEMORRHAGIC ESCHERICHIA COLI, AND METHOD FOR DETECTING ENTEROHEMORRHAGIC ESCHERICHIA COLI IN SPECIMEN 富士フイルム株式会社 2023-03-23 WO disclosed
EP-3747956-A1 STAINING COMPOSITION, STAINED ARTICLE, AND AZO DYE FUJIFILM Corporation (JP) 2020-12-09 EP disclosed
US-20040019982-A1 Hair dye composition KAO CORPORATION (JP) 2004-02-05 US disclosed
EP-1369105-A1 Hair dye composition Kao Corporation (JP) 2003-12-10 EP disclosed
EP-1366752-A1 Hair dye composition Kao Corporation (JP) 2003-12-03 EP disclosed
EP-1329160-A2 4-ACYLAMINOPYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-07-23 EP disclosed
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed
US-4851535-A 2-(5-FLUORONICOTINOYL)ACETIC ACID DERIVATIVES, ANTIBACTERIAL 1-ARYL-1,4-DIHYDRO-4-OXONAPHTHYRIDINES TOYAMA CHEMICAL CO., LTD. (JP) 1989-07-25 US disclosed
US-4704459-A VILSMEIER REAGENT TOYAMA CHEMICAL CO., LTD. (JP) 1987-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019982-A1 Hair dye composition CYBA, SDHB, S100B CYP3A4 553/4885LPAR3 4803/4885LPAR1 4763/4885
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 CYP3A4 1294/4885LPAR3 1891/4885LPAR1 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.